Form 4: Establishment Labs Holdings Inc. Director Awarded Stock Options

Director Nicholas Sheridan Lewin receives stock options for Establishment Labs Holdings Inc. under the 2018 Equity Incentive Plan.

Summary

• Nicholas Sheridan Lewin, a director of Establishment Labs Holdings Inc., was granted stock options on May 14, 2025.
• The options, awarded under the Issuer's 2018 Equity Incentive Plan, allow him to purchase 36,027 common shares at an exercise price of $36.46.
• The options vest in four equal annual installments, starting on May 14, 2026, contingent upon continued service as a provider.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for the director, aligning their interests with shareholders.

Positives

• The granting of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's success.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Management Comments

• Rajbir S. Denhoy, Chief Financial Officer, signed the document by power of attorney.

Industry Context

Stock option grants are a common practice in the corporate world to incentivize and retain key personnel, particularly directors and executives. This grant aligns with standard compensation practices.

Comparison to Industry Standards

• Stock option grants are a common component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like medical technology, where Establishment Labs operates.
• Comparable companies such as Sientra or Allergan (now part of AbbVie) also utilize stock options as part of their executive compensation plans.
• The vesting schedule of one-fourth annually is a typical structure to ensure continued service and alignment with long-term company performance.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director.
• The director is incentivized to contribute to the company's long-term success.

Key Dates

Keywords

stock options, Establishment Labs Holdings Inc., director, equity incentive plan, vesting, ESTA, Form 4